Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod

Clinical trial NCT06356012 · RECRUITING

Trial details

NCT number: NCT06356012
Sponsor: Barretos Cancer Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

HSIL, High-Grade Squamous Intraepithelial Lesions Vaginal Microbiome Biomarkers

Start date: 2024-04-02
Primary completion: 2026-12-31
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.